Sign in
4

Changes in Ownership

Silence Therapeutics plc Filed Acc 0002048873-25-000005

Options or other derivatives

  • Director acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ede-Golightly James Director 2025-12-22 Grant or award · Share Option (Right to Buy) +90,000 90,000 D: show line 1 in the form
Loading xslF345X05/form4-12222025_111219.xml…